Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,172,698
  • Shares Outstanding, K 53,503
  • Annual Sales, $ 110,320 K
  • Annual Income, $ -70,690 K
  • 60-Month Beta 0.23
  • Price/Sales 37.53
  • Price/Cash Flow N/A
  • Price/Book 8.44
Trade ACLX with:

Options Overview Details

View History
  • Implied Volatility 50.29% ( -0.23%)
  • Historical Volatility 50.54%
  • IV Percentile 11%
  • IV Rank 15.41%
  • IV High 89.87% on 12/08/23
  • IV Low 43.07% on 08/28/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 25,218
  • Volume Avg (30-Day) 1,379
  • Put/Call OI Ratio 1.29
  • Today's Open Interest 7,840
  • Open Int (30-Day) 7,030

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.54
  • Number of Estimates 7
  • High Estimate 0.05
  • Low Estimate -0.82
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.10 +25.66%
on 09/04/24
82.97 -2.92%
on 09/18/24
+15.27 (+23.39%)
since 08/16/24
3-Month
49.00 +64.39%
on 08/05/24
82.97 -2.92%
on 09/18/24
+26.74 (+49.69%)
since 06/18/24
52-Week
30.88 +160.85%
on 10/27/23
82.97 -2.92%
on 09/18/24
+46.66 (+137.68%)
since 09/18/23

Most Recent Stories

More News
2 Potential Stocks to Buy From Barchart’s ‘Death Cross’ Indicator

While a security’s short-term moving average dipping below its long-term average warrants caution, this dynamic may also be a contrarian indicator.

IRTC : 71.03 (-0.67%)
ACLX : 80.55 (+3.28%)
Chart of the Day: Arcellx - Reimagining Cell Therapy

The Chart of the Day belongs to the immunotherapy company Arcellx (ACLX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

ACLX : 80.55 (+3.28%)
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 80.55 (+3.28%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 80.55 (+3.28%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 80.55 (+3.28%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 80.55 (+3.28%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 80.55 (+3.28%)
Stocks End Moderately Lower Ahead of Powell’s Testimony to Congress

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.72%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,618.26 (-0.29%)
SPY : 561.40 (-0.30%)
$DOWI : 41,503.10 (-0.25%)
DIA : 416.19 (-0.26%)
$IUXX : 19,344.49 (-0.45%)
QQQ : 471.44 (-0.43%)
HAL : 29.10 (-0.68%)
DVN : 40.37 (-0.22%)
PSX : 130.31 (+1.57%)
APA : 25.11 (-0.55%)
CVX : 143.96 (+0.38%)
COP : 108.62 (+0.30%)
Stocks Fall on Chinese Economic Concerns and Wariness Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.73%....

$SPX : 5,618.26 (-0.29%)
SPY : 561.40 (-0.30%)
$DOWI : 41,503.10 (-0.25%)
DIA : 416.19 (-0.26%)
$IUXX : 19,344.49 (-0.45%)
QQQ : 471.44 (-0.43%)
APA : 25.11 (-0.55%)
HAL : 29.10 (-0.68%)
DVN : 40.37 (-0.22%)
MRO : 27.43 (+0.26%)
VLO : 136.66 (+0.63%)
CVX : 143.96 (+0.38%)
Markets Today: Stocks Slip on China Economic Concerns and Higher Bond Yields

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.33%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.28%. U.S. stock index futures this morning are moderately...

ESZ24 : 5,680.00s (-0.36%)
NQZ24 : 19,580.50s (-0.48%)
NKE : 80.90 (+0.32%)
PDD : 98.23 (-0.15%)
JD : 26.92 (unch)
BABA : 84.42 (-0.33%)
NTES : 76.70 (-0.42%)
SOFI : 8.11 (-0.12%)
AMAT : 186.14 (-1.30%)
ACLX : 80.55 (+3.28%)
WBD : 8.42 (-0.36%)
DICE : 47.55 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 87.94
2nd Resistance Point 85.46
1st Resistance Point 83.00
Last Price 80.55
1st Support Level 78.06
2nd Support Level 75.58
3rd Support Level 73.12

See More

52-Week High 82.97
Last Price 80.55
Fibonacci 61.8% 63.07
Fibonacci 50% 56.92
Fibonacci 38.2% 50.78
52-Week Low 30.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar